AbCellera Biologics (ABCL) Gross Margin (2021 - 2023)
AbCellera Biologics (ABCL) posted Gross Margin of 100.0% for Q4 2023, little changed on a QoQ basis from 100.0% in Q3 2023, and up 696.0% year-over-year from 12.56% in Q4 2022.
AbCellera Biologics (ABCL) Gross Margin (2021 - 2023) Analysis & Trends
AbCellera Biologics' Gross Margin history runs 3 years deep, the most recent figure standing at 100.0% for Q4 2023.
- Quarterly Gross Margin rose 696.0% year-over-year to 100.0% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 100.0% (up 1367.0% YoY) and the FY2024 annual result came in at 100.0%, changed 0.0% from the prior year.
- Gross Margin was 100.0% for Q4 2023 at AbCellera Biologics, roughly flat from 100.0% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q3 2021 and bottomed at 84.29% in Q4 2021.
- A 3-year average of 92.85% and a median of 91.58% in 2021 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin slumped 1480 bps — and 2023, when it surged 1480 bps.
- AbCellera Biologics' Gross Margin stood at 84.29% in 2021, then rose by 10 bps to 93.04% in 2022, then advanced by 7 bps to 100.0% in 2023.
- Business Quant data shows ABCL's Gross Margin at 100.0% in Q4 2023, 100.0% in Q3 2023, and 100.0% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 90.68% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 93.04% |
| Sep 30, 2022 | 85.20% |
| Jun 30, 2022 | 88.65% |
| Mar 31, 2022 | 85.90% |
| Dec 31, 2021 | 84.29% |
| Sep 30, 2021 | 100.00% |
| Jun 30, 2021 | 86.94% |
| Mar 31, 2021 | 90.13% |